Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621578 | SCV000737417 | likely benign | Cardiovascular phenotype | 2016-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000860835 | SCV001001000 | benign | Long QT syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692229 | SCV001914410 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253538 | SCV002525001 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002253538 | SCV002806453 | likely benign | Cardiac arrhythmia, ankyrin-B-related | 2021-07-23 | criteria provided, single submitter | clinical testing |